LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTMRG003 CLINICAL TRIAL RESULTS SELECTED ASLBA FOR ORAL PRESENTATION AT 2025 ASCO ANNUAL MEETING
LEPU BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024
LEPU BIO-B: NOTICE OF BOARD MEETING
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
LEPU BIO-B: VOLUNTARY ANNOUNCEMENTUPDATE ON NEW DRUG APPLICATION OF MRG003
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
LEPU BIO-B: INSIDE INFORMATION ANNOUNCEMENT EXCLUSIVE LICENSE AGREEMENT FOR NOVEL ADC MRG007
LEPU BIO-B: CHANGE OF ADDRESSOF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
LEPU BIO-B: POLL RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON JANUARY 7, 2025
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
LEPU BIO-B: NOTICE OF 2025 FIRST EXTRAORDINARY GENERAL MEETING
LEPU BIO-B: PROXY FORM FOR USE AT THE 2025 FIRST EXTRAORDINARY GENERAL MEETING
LEPU BIO-B: (1) CONTINUING CONNECTED TRANSACTION IN RELATION TOCDMO SERVICES FRAMEWORK AGREEMENT(2) PROPOSED CHANGE OF THE AUDITORAND(3) NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERALMEETING
LEPU BIO-B: CLOSURE OF REGISTER OF MEMBERS FORTHE 2025 FIRST EXTRAORDINARYGENERAL MEETINGS TO BE HELD ON JANUARY 7, 2025
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
LEPU BIO-B: CONTINUING CONNECTED TRANSACTIONCDMO SERVICES FRAMEWORK AGREEMENT
LEPU BIO-B: ANNOUNCEMENT OFPROPOSED CHANGE OF AUDITOR
LEPU BIO-B: CONTINUING CONNECTED TRANSACTIONNEW PROCUREMENT FRAMEWORK AGREEMENT
LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024